Strata Critical Medical, Inc.
SRTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $49,298 | $70,801 | $54,306 | $54,357 |
| % Growth | -30.4% | 30.4% | -0.1% | – |
| Cost of Goods Sold | $37,684 | $53,064 | $42,328 | $41,768 |
| Gross Profit | $11,614 | $17,737 | $11,978 | $12,589 |
| % Margin | 23.6% | 25.1% | 22.1% | 23.2% |
| R&D Expenses | $453 | $915 | $812 | $743 |
| G&A Expenses | $11,256 | $20,142 | $17,314 | $18,954 |
| SG&A Expenses | $11,738 | $21,776 | $18,749 | $20,218 |
| Sales & Mktg Exp. | $482 | $1,634 | $1,435 | $1,264 |
| Other Operating Expenses | $5,045 | $0 | $0 | $0 |
| Operating Expenses | $17,236 | $22,691 | $19,561 | $20,961 |
| Operating Income | -$5,622 | -$4,954 | -$7,583 | -$8,372 |
| % Margin | -11.4% | -7% | -14% | -15.4% |
| Other Income/Exp. Net | -$4,035 | $1,232 | $4,073 | -$1,526 |
| Pre-Tax Income | -$9,657 | -$3,722 | -$3,510 | -$9,898 |
| Tax Expense | $0 | $21 | -$17 | -$105 |
| Net Income | $57,416 | -$3,743 | -$3,493 | -$9,793 |
| % Margin | 116.5% | -5.3% | -6.4% | -18% |
| EPS | 0.7 | -0.046 | -0.04 | -0.12 |
| % Growth | 1,621.7% | -15% | 66.7% | – |
| EPS Diluted | 0.7 | -0.046 | -0.04 | -0.12 |
| Weighted Avg Shares Out | 82,455 | 81,297 | 79,892 | 79,419 |
| Weighted Avg Shares Out Dil | 82,455 | 81,297 | 79,892 | 79,419 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,127 | $1,155 | $1,321 | $1,590 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $419 | $1,776 | $1,697 | $1,530 |
| EBITDA | -$9,238 | -$3,178 | -$5,886 | -$6,842 |
| % Margin | -18.7% | -4.5% | -10.8% | -12.6% |